CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 258 filers reported holding CRISPR THERAPEUTICS AG in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $343,000 | -38.6% | 5,468 | -25.9% | 0.02% | -47.1% |
Q4 2021 | $559,000 | -39.5% | 7,380 | -10.6% | 0.03% | -34.6% |
Q3 2021 | $924,000 | +4.6% | 8,254 | +43.1% | 0.05% | -18.8% |
Q4 2020 | $883,000 | -50.8% | 5,770 | -73.1% | 0.06% | +10.3% |
Q3 2020 | $1,796,000 | -53.6% | 21,472 | -59.2% | 0.06% | -42.0% |
Q2 2020 | $3,870,000 | +9.9% | 52,662 | -36.5% | 0.10% | +7.5% |
Q1 2020 | $3,520,000 | +10.1% | 82,992 | +58.0% | 0.09% | +106.7% |
Q4 2019 | $3,198,000 | – | 52,515 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |